The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells

Endocrinology

Volumn 143, Issue 2, 2002, Pages 484-491

  Ghé, Corrado ^a   Cassoni, Paola ^a   Catapano, Filomena ^a   Marrocco, Tiziana ^a   Deghenghi, Romano ^c   Ghigo, Ezio ^b   Muccioli, Giampiero ^a   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GHRELIN; GROWTH HORMONE SECRETAGOGUE; HEXARELIN; IBUTAMOREN; MESSENGER RNA; SOMATOMEDIN B; SYNTHETIC PEPTIDE; THYMIDINE; TYROSINE;

ADULT; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 0036155811     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.2.8654     Document Type: Article

References (39)

1. Growth hormone-releasing peptides and their analogs
2. Growth hormone secretagogues: Physiological role and clinical utility
3. Identification of a new G-protein-linked receptor for growth hormone secretagogues
4. A receptor in pituitary and hypothalamus that functions in growth hormone release
5. Peptidomimetic regulation of growth hormone secretion
6. Ghrelin is a growth hormone-releasing acylated peptide from stomach
7. Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
8. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a
9. 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland
10. Ghrelin elicits a marked stimulatory effect on GH secretion in freelymoving rats
11. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone
12. Unnatural growth hormone-releasing peptide begets natural ghrelin
13. Growth hormone secretagogue receptor family members and ligands
14. Presence of specific receptors for synthetic growth hormone secretagogues in the human heart
15. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart
16. CD36 mediates the cardiovascular activity of hexarelin in the heart
17. Binding sites for growth hormone-releasing peptide
18. Growth hormone secretagogue binding sites in peripheral human tissues
19. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers
20. Growth hormoneindependent cardioprotective effects of hexarelin in the rat
21. Growth hormone-releasing peptides and the cardiovascular system
22. Biological activities of growth hormone secretagogues in humans
23. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue
24. Identification, characterization and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines
25. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland
26. Identification of a pituitary GHRP receptor subtype by the photoaffinity labeling approach
27. Tyr-Ala-hexarelin, a synthetic octapeptide, possesses the same endocrine activities of hexarelin and GHRP2 in humans
28. Protein measurement with the Folin phenol reagent
29. The attraction of proteins for small molecules and ions
30. Correlative immunohistochemical and reverse transcriptase-polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung
31. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors
32. Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormonereleasing hormone in vitro
33. Antitumorigenic actions of growth hormone-releasing hormone antagonists
34. Somatostatin, its receptors and analogs, in lung cancer
35. Cloning and characterization of two human G-protein-coupled receptor genes (GPR38 and GPR39) related to growth hormone secretagogue and neurotensin receptors
36. Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors
37. Growth hormone releasing substances: Types and their receptors